Skip to content
Try Mental Wellness – Lifestyle
Author:
Alzamend Neuro, Inc.
Alzamend Neuro’s Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
August 20, 2026
Alzamend Neuro’s Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain
August 18, 2026
Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending
August 4, 2026